Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

NCT02639117 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Basal Cell Carcinoma

Interventions

DRUG: Vismodegib

Sponsor

University of Arizona

Collaborators

[object Object]